
Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability
Keywords: آنفلوانزا A; SMID; severe motor and intellectual disability; EMEA; European Medicines Evaluation Agency; FDA; Food and Drug Administration; GMTR; geometric mean titer ratio; HAI; hemagglutination-inhibition; Disabled person; H1N1; Immunogenicity; Influenza A; Influenz